A single dose of a drug shows potential to cure and prevent Malaria
Advertisement
Now, don’t just reduce the burden of the disease, but also cure it immediately with one effective dose to kill the parasite in the liver and blood stream
Researchers seem to have found a wonder drug to cure malaria in one effective dose. The Drug, DSM265, has shown the potential to kill drug-resistant malaria parasites in the blood and liver by targeting their ability to replicate. Till now, the treatment for malaria has been reactive, and helps only to reduce the burden of the disease on those infected. However, recent few cases have emerged with developed drug resistance to malaria, which is a matter of concern.
The front-line anti-malarial treatments are artemisinin-based combination therapies, or ACTs, which are credited with helping to reduce the malaria burden. However, malaria strains resistant to ACTs have recently been reported in some countries including, Thailand, Cambodia, Vietnam, Myanmar, and Laos.
As reported by IANS,
The compound, invented by an international team of researchers, including Indian-origin Pradipsinh Rathod from the University of Washington, is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, the study noted.
Researchers seem to have found a wonder drug to cure malaria in one effective dose. The Drug, DSM265, has shown the potential to kill drug-resistant malaria parasites in the blood and liver by targeting their ability to replicate. Till now, the treatment for malaria has been reactive, and helps only to reduce the burden of the disease on those infected. However, recent few cases have emerged with developed drug resistance to malaria, which is a matter of concern.
The front-line anti-malarial treatments are artemisinin-based combination therapies, or ACTs, which are credited with helping to reduce the malaria burden. However, malaria strains resistant to ACTs have recently been reported in some countries including, Thailand, Cambodia, Vietnam, Myanmar, and Laos.
As reported by IANS,
The compound, invented by an international team of researchers, including Indian-origin Pradipsinh Rathod from the University of Washington, is the first to cripple a critical protein that the malaria parasite needs to survive at different stages of its complex life cycle, the study noted.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.